Ushbu ish iqtibos qilgan ishlar

186 ta ish

Ish: Outsmarting Antigen Escape: Next‐Generation <scp>CAR</scp> T Cell Engineering Strategies for Durable Remissions in Hematologic Malignancies

1. Precisely Tailoring Molecular Structure of Doxorubicin Prodrugs to Enable Stable Nanoassembly, Rapid Activation, and Potent Antitumor Effect

   Chengcheng Feng, Yuting Wang, Jinghua Xu +5

   MaqolaOAOchiq kirish202412 iqtibos

   ABIABI:AkademIndex/2026.other.112364

2. Unlocking the full potential of memory T cells in adoptive T cell therapy for hematologic malignancies

   Ding-Ya Sun, Yijie Hu, Xin Li +3

   Sharh maqola202412 iqtibos

   ABIABI:AkademIndex/2026.other.462660

3. The Benefits and Safety of Monoclonal Antibodies: Implications for Cancer Immunotherapy

   Shuguang Zhang, Wen‐Ying Chen, Jihong Zhou +5

   Sharh maqola20259 iqtibos

   ABIABI:AkademIndex/2026.other.340938

4. CAR-T cell therapy for cancer: current challenges and future directions

   Inés Zugasti, Lady Espinosa-Aroca, Klaudyna Fidyt +7

   Sharh maqola20259 iqtibos

   ABIABI:AkademIndex/2026.other.830985

5. A <scp>TGF</scp>‐β signaling‐related <scp>lncRNA</scp> signature for prediction of glioma prognosis, immune microenvironment, and immunotherapy response

   Weiwei Duan, Liting Yang, Jian Liu +13

   Maqola20238 iqtibos

   ABIABI:AkademIndex/2026.other.316100

6. The Burgeoning Significance of Liquid-Liquid Phase Separation in the Pathogenesis and Therapeutics of Cancers

   Wei-Xin Xu, Qiang Qu, Hai-Hui Zhuang +5

   Maqola20248 iqtibos

   ABIABI:AkademIndex/2026.other.480230

7. Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia

   Shannon L. Maude, Theodore W. Laetsch, Jochen Buechner +32

   Maqola20187 iqtibos

   ABIABI:AkademIndex/2026.other.312621

8. Aptamer-based approaches in leukemia: a paradigm shift in targeted therapy

   Alireza Bayani, Munthar Kadhim Abosaoda, Jasur Rizaev +3

   Sharh maqolaOAOchiq kirishAdvanced biosensing and bioanalysis techniquesClinical and Experimental Medicine20255 iqtibos

   ABIABI:AkademIndex/2025.review-article.000015

9. Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma

   Noopur Raje, Jesús G. Berdeja, Yi Lin +20

   MaqolaOAOchiq kirish20195 iqtibos

   ABIABI:AkademIndex/2026.other.082848

10. CAR-T cell therapy: current limitations and potential strategies

    Robert C. Sterner, Rosalie M. Sterner

    Sharh maqolaOAOchiq kirish20215 iqtibos

    ABIABI:AkademIndex/2026.other.102886

11. A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma

    Donald M. O’Rourke, MacLean P. Nasrallah, Arati Desai +18

    MaqolaOAOchiq kirish20174 iqtibos

    ABIABI:AkademIndex/2026.other.020482

12. Sarlavhasiz

    Boshqa4 iqtibos

    ABIABI:AkademIndex/2026.other.300368

13. Engineering and Design of Chimeric Antigen Receptors

    Sònia Guedan, Hugo Calderón, Avery D. Posey +1

    Sharh maqola20184 iqtibos

    ABIABI:AkademIndex/2026.other.340858

14. Sarlavhasiz

    Boshqa4 iqtibos

    ABIABI:AkademIndex/2026.other.931878

15. γ-Secretase inhibition increases efficacy of BCMA-specific chimeric antigen receptor T cells in multiple myeloma

    Margot J. Pont, Tyler Hill, Gabriel O. Cole +14

    MaqolaOAOchiq kirish20193 iqtibos

    ABIABI:AkademIndex/2026.other.020527

16. A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combination with the Anti–PD-1 Agent Pembrolizumab

    Prasad S. Adusumilli, Marjorie G. Zauderer, Isabelle Rivière +27

    MaqolaOAOchiq kirish20213 iqtibos

    ABIABI:AkademIndex/2026.other.102892

17. Sarlavhasiz

    Boshqa3 iqtibos

    ABIABI:AkademIndex/2026.other.138193

18. Two for one: targeting BCMA and CD19 in B-cell malignancies with off-the-shelf dual-CAR NK-92 cells

    Gils Roex, Diana Campillo-Davó, Donovan Flumens +6

    Maqola20223 iqtibos

    ABIABI:AkademIndex/2026.other.296901

19. Dual-targeting CAR-T cells with optimal co-stimulation and metabolic fitness enhance antitumor activity and prevent escape in solid tumors

    Koichi Hirabayashi, Hongwei Du, Yang Xu +8

    Maqola20213 iqtibos

    ABIABI:AkademIndex/2026.other.340879

20. Trogocytosis of CAR molecule regulates CAR-T cell dysfunction and tumor antigen escape

    You Zhai, Yicong Du, Guanzhang Li +9

    Maqola20233 iqtibos

    ABIABI:AkademIndex/2026.other.431625

21. Sarlavhasiz

    Boshqa3 iqtibos

    ABIABI:AkademIndex/2026.other.870281

22. Sarlavhasiz

    Boshqa3 iqtibos

    ABIABI:AkademIndex/2026.other.912904

23. Sarlavhasiz

    BoshqaOAOchiq kirish2 iqtibos

    ABIABI:AkademIndex/2026.other.020401

24. Sarlavhasiz

    Boshqa2 iqtibos

    ABIABI:AkademIndex/2026.other.020440

25. Sarlavhasiz

    Boshqa2 iqtibos

    ABIABI:AkademIndex/2026.other.020464